Hepatitis C Virus: Strategies to Evade Antiviral Responses

References

• Averhoff FM , GlassN , HoltzmanD . Global burden of hepatitis C: considerations for healthcare providers in the United States . Clin. Infect. Dis.55 ( Suppl. 1 ), S10 – S15 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lavanchy D . The global burden of hepatitis C . Liver Int.29 ( Suppl. 1 ), 74 – 81 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Sarrazin C , HezodeC , ZeuzemS , PawlotskyJM . Antiviral strategies in hepatitis C virus infection . J. Hepatol.56S88 – S100 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lange CM , ZeuzemS . Perspectives and challenges of interferon-free therapy for chronic hepatitis C . J. Hepatol.58 ( 3 ), 583 – 592 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Feeney ER , ChungRT . Antiviral treatment of hepatitis C . BMJ349 , g3308 ( 2014 ).
   Web of Science ®Google Scholar
• Rotman Y , LiangTJ . Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes . J. Virol.83 ( 15 ), 7366 – 7374 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Moradpour D , PeninF , RiceCM . Replication of hepatitis C virus . Nat. Rev. Microbiol.5 ( 6 ), 453 – 463 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Rehermann B . Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells . Nat. Med.19 ( 7 ), 859 – 868 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Thomas DL , ThioCL , MartinMPet al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus . Nature461 ( 7265 ), 798 – 801 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Ge D , FellayJ , ThompsonAJet al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance . Nature461 ( 7262 ), 399 – 401 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Horner SM , GaleMJr . Regulation of hepatic innate immunity by hepatitis C virus . Nat. Med.19 ( 7 ), 879 – 888 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sumpter R Jr. , LooYM , FoyEet al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I . J. Virol.79 ( 5 ), 2689 – 2699 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Israelow B , NarbusCM , SourisseauM , EvansMJ . HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection . Hepatology60 ( 4 ), 1170 – 1179 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Goubau D , DeddoucheS , ReisESC . Cytosolic Sensing of Viruses . Immunity38 ( 5 ), 855 – 869 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Baum A , SachidanandamR , Garcia-SastreA . Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing . Proc. Natl Acad. Sci. USA107 ( 37 ), 16303 – 16308 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Schnell G , LooYM , MarcotrigianoJ , GaleMJr . Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I . PLoS Pathog.8 ( 8 ), e1002839 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Saito T , GaleM , Jr . Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity . J. Exp. Med.205 ( 7 ), 1523 – 1527 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Uzri D , GehrkeL . Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities . J. Virol.83 ( 9 ), 4174 – 4184 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Goubau D , SchleeM , DeddoucheSet al. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates . Nature514 ( 7522 ), 372 – 375 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Luo D , DingSC , VelaA , KohlwayA , LindenbachBD , PyleAM . Structural insights into RNA recognition by RIG-I . Cell147 ( 2 ), 409 – 422 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Jiang F , RamanathanA , MillerMTet al. Structural basis of RNA recognition and activation by innate immune receptor RIG-I . Nature479 ( 7373 ), 423 – 427 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kowalinski E , LunardiT , MccarthyAAet al. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA . Cell147 ( 2 ), 423 – 435 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wu B , PeisleyA , RichardsCet al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5 . Cell152 ( 1–2 ), 276 – 289 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Peisley A , WuB , YaoH , WalzT , HurS . RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner . Mol. Cell51 ( 5 ), 573 – 583 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Peisley A , WuB , XuH , ChenZJ , HurS . Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I . Nature509 ( 7498 ), 110 – 114 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Saito T , HiraiR , LooYMet al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2 . Proc. Natl Acad. Sci. USA104 ( 2 ), 582 – 587 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Oshiumi H , MiyashitaM , MatsumotoM , SeyaT . A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses . PLoS Pathog.9 ( 8 ), e1003533 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gack MU , ShinYC , JooCHet al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity . Nature446 ( 7138 ), 916 – 920 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Wies E , WangMK , MaharajNPet al. Dephosphorylation of the RNA Sensors RIG-I and MDA5 by the Phosphatase PP1 is essential for innate immune signaling . Immunity38 ( 3 ), 437 – 449 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kato H , TakeuchiO , Mikamo-SatohEet al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5 . J. Exp. Med.205 ( 7 ), 1601 – 1610 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Pichlmair A , SchulzO , TanCPet al. Activation of MDA5 requires higher-order RNA structures generated during virus infection . J. Virol.83 ( 20 ), 10761 – 10769 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Triantafilou K , VakakisE , KarS , RicherE , EvansGL , TriantafilouM . Visualisation of direct interaction of MDA5 and the dsRNA replicative intermediate form of positive strand RNA viruses . J. Cell Sci.125 ( Pt 20 ), 4761 – 4769 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Peisley A , LinC , WuBet al. Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition . Proc. Natl Acad. Sci. USA108 ( 52 ), 21010 – 21015 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Schoggins JW , WilsonSJ , PanisMet al. A diverse range of gene products are effectors of the type I interferon antiviral response . Nature472 ( 7344 ), 481 – 485 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Andrus L , MarukianS , JonesCTet al. Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells . Hepatology54 ( 6 ), 1901 – 1912 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hoffmann F , SchmidtA , Dittmann ChevillotteMet al. Polymorphisms in MDA-5 link protein function to clearance of hepatitis C virus . Hepatology doi: 10.1002/hep.27344 ( 2014 ) ( Epub ahead of print ).
   Google Scholar
• Errett JS , SutharMS , McmillanA , DiamondMS , GaleMJr . The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection . J. Virol.87 ( 21 ), 11416 – 11425 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Dixit E , BoulantS , ZhangYet al. Peroxisomes are signaling platforms for antiviral innate immunity . Cell141 ( 4 ), 668 – 681 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Horner SM , LiuHM , ParkHS , BrileyJ , GaleMJr . Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus . Proc. Natl Acad. Sci. USA108 ( 135 ) 14590 – 14595 ( 2011 ).
   PubMedGoogle Scholar
• Seth RB , SunL , EaCK , ChenZJ . Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3 . Cell122 ( 5 ), 669 – 682 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Liu HM , LooYM , HornerSM , ZornetzerGA , KatzeMG , GaleMJr . The Mitochondrial targeting chaperone 14–13–3epsilon regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity . Cell Host Microbe11 ( 5 ), 528 – 537 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Baril M , RacineME , PeninF , LamarreD . MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease . J. Virol.83 ( 3 ), 1299 – 1311 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hou F , SunL , ZhengH , SkaugB , JiangQX , ChenZJ . MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response . Cell146 ( 3 ), 448 – 461 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Tang ED , WangCY . MAVS self-association mediates antiviral innate immune signaling . J. Virol.83 ( 8 ), 3420 – 3428 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Dixit E , KaganJC . Intracellular pathogen detection by RIG-I-like receptors . Adv. Immunol.117 , 99 – 125 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Odendall C , DixitE , StavruFet al. Diverse intracellular pathogens activate type III interferon expression from peroxisomes . Nat. Immunol. ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Okamoto M , OshiumiH , AzumaM , KatoN , MatsumotoM , SeyaT . IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection . J. Immunol.192 ( 6 ), 2770 – 2777 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zhang YL , GuoYJ , BinL , SunSH . Hepatitis C virus single-stranded RNA induces innate immunity via Toll-like receptor 7 . J. Hepatol.51 ( 1 ), 29 – 38 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Li K , LiNL , WeiD , PfefferSR , FanM , PfefferLM . Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates . Hepatology55 ( 3 ), 666 – 675 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wang N , LiangY , DevarajS , WangJ , LemonSM , LiK . Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells . J. Virol.83 ( 19 ), 9824 – 9834 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Takahashi K , AsabeS , WielandSet al. Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection . Proc. Natl Acad. Sci. USA107 ( 16 ), 7431 – 7436 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Dreux M , GaraigortaU , BoydBet al. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity . Cell Host Microbe12 ( 4 ), 558 – 570 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Horner SM , GaleM , Jr . Intracellular innate immune cascades and interferon defenses that control hepatitis C virus . J. Interferon Cytokine Res.29 ( 9 ), 489 – 498 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Negash AA , RamosHJ , CrochetNet al. IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease . PLoS Pathog.9 ( 4 ), e1003330 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chattergoon MA , LatanichR , QuinnJet al. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon . PLoS Pathog.10 ( 5 ), e1004082 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Shrivastava S , MukherjeeA , RayR , RayRB . Hepatitis C virus induces interleukin-1beta (IL-1beta)/IL-18 in circulatory and resident liver macrophages . J. Virol.87 ( 22 ), 12284 – 12290 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Arnaud N , DaboS , AkazawaDet al. Hepatitis C virus reveals a novel early control in acute immune response . PLoS Pathog.7 ( 10 ), e1002289 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Garaigorta U , ChisariFV . Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation . Cell Host Microbe6 ( 6 ), 513 – 522 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Shimoike T , MckennaSA , LindhoutDA , PuglisiJD . Translational insensitivity to potent activation of PKR by HCV IRES RNA . Antiviral Res.83 ( 3 ), 228 – 237 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Onomoto K , JogiM , YooJSet al. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity . PLoS ONE7 ( 8 ), e43031 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Pager CT , SchutzS , AbrahamTM , LuoG , SarnowP . Modulation of hepatitis C virus RNA abundance and virus release by dispersion of processing bodies and enrichment of stress granules . Virology435 ( 2 ), 472 – 484 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ruggieri A , DazertE , MetzPet al. Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection . Cell Host Microbe12 ( 1 ), 71 – 85 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ariumi Y , KurokiM , KushimaYet al. Hepatitis C virus hijacks P-body and stress granule components around lipid droplets . J. Virol.85 ( 14 ), 6882 – 6892 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Garaigorta U , HeimMH , BoydB , WielandS , ChisariFV . Hepatitis C virus (HCV) induces formation of stress granules whose proteins regulate HCV RNA replication and virus assembly and egress . J. Virol.86 ( 20 ), 11043 – 11056 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ding Q , CaoX , LuJet al. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity . J. Hepatol.59 ( 1 ), 52 – 58 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Brass V , BerkeJM , MontserretR , BlumHE , PeninF , MoradpourD . Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3–4A complex . Proc. Natl Acad. Sci. USA105 ( 38 ), 14545 – 14550 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Morikawa K , LangeCM , GouttenoireJet al. Nonstructural protein 3–4A: the Swiss army knife of hepatitis C virus . J. Viral Hepat.18 ( 5 ), 305 – 315 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wolk B , SansonnoD , KrausslichHGet al. Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines . J. Virol.74 ( 5 ), 2293 – 2304 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Kang X , ChenX , HeYet al. DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication . Virology435 ( 2 ), 385 – 394 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Li XD , SunL , SethRB , PinedaG , ChenZJ . Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity . Proc. Natl Acad. Sci. USA102 ( 49 ), 17717 – 17722 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Meylan E , CurranJ , HofmannKet al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus . Nature437 ( 7062 ), 1167 – 1172 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Loo YM , OwenDM , LiKet al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection . Proc. Natl Acad. Sci. USA103 ( 15 ), 6001 – 6006 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Bellecave P , Sarasin-FilipowiczM , DonzeOet al. Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system . Hepatology51 ( 4 ), 1127 – 1136 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Schoggins JW , RiceCM . Innate immune responses to hepatitis C virus . Curr. Top. Microbiol. Immunol.369 , 219 – 242 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Rajsbaum R , AlbrechtRA , WangMKet al. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein . PLoS Pathog.8 ( 11 ), e1003059 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Li K , FoyE , FerreonJCet al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF . Proc. Natl Acad. Sci. USA102 ( 8 ), 2992 – 2997 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Zhang Z , KimT , BaoMet al. DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells . Immunity34 ( 6 ), 866 – 878 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yang Y , LiangY , QuLet al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor . Proc. Natl Acad. Sci. USA104 ( 17 ), 7253 – 7258 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Qu L , FengZ , YamaneDet al. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD . PLoS Pathog.7 ( 9 ), 1002169 ( 2011 ).
   Web of Science ®Google Scholar
• Romero-Brey I , MerzA , ChiramelAet al. Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication . PLoS Pathog.8 ( 12 ), e1003056 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kim SJ , SyedGH , KhanMet al. Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence . Proc. Natl Acad. Sci. USA111 ( 17 ), 6413 – 6418 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Castanier C , GarcinD , VazquezA , ArnoultD . Mitochondrial dynamics regulate the RIG-I-like receptor antiviral pathway . EMBO Rep.11 ( 2 ), 133 – 138 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Pagliaccetti NE , RobekMD . Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus . J. Interferon Cytokine Res.30 ( 8 ), 585 – 590 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kelly C , KlenermanP , BarnesE . Interferon lambdas: the next cytokine storm . Gut60 ( 9 ), 1284 – 1293 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Sommereyns C , PaulS , StaeheliP , MichielsT . IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo . PLoS Pathog.4 ( 3 ), e1000017 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Park H , SertiE , EkeOet al. IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection . Hepatology56 ( 6 ), 2060 – 2070 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Thomas E , GonzalezVD , LiQet al. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons . Gastroenterology142 ( 4 ), 978 – 988 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Marukian S , AndrusL , SheahanTPet al. Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures . Hepatology54 ( 6 ), 1913 – 1923 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Marcello T , GrakouiA , Barba-SpaethGet al. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics . Gastroenterology131 ( 6 ), 1887 – 1898 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Rauch A , KutalikZ , DescombesPet al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study . Gastroenterology138 ( 4 ), 1338 – 1345 , 1345 , e1331 – 1337 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Suppiah V , MoldovanM , AhlenstielGet al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy . Nat. Genet.41 ( 10 ), 1100 – 1104 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Tanaka Y , NishidaN , SugiyamaMet al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C . Nat. Genet.41 ( 10 ), 1105 – 1109 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Dill MT , DuongFH , VogtJEet al. Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C . Gastroenterology140 ( 3 ), 1021 – 1031 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Langhans B , KupferB , BraunschweigerIet al. Interferon-lambda serum levels in hepatitis C . J. Hepatol.54 ( 5 ), 859 – 865 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yoshio S , KantoT , KurodaSet al. Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-lambda in response to hepatitis C virus . Hepatology57 ( 5 ), 1705 – 1715 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Fukuhara T , TaketomiA , MotomuraTet al. Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C . Gastroenterology139 ( 5 ), 1577 – 1585 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sheahan T , ImanakaN , MarukianSet al. Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness . Cell Host Microbe15 ( 2 ), 190 – 202 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mcfarland AP , HornerSM , JarretAet al. The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs . Nat. Immunol.15 ( 1 ), 72 – 79 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Prokunina-Olsson L , MuchmoreB , TangWet al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus . Nat. Genet.45 ( 2 ), 164 – 171 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• De Castellarnau M , AparicioE , PareraMet al. Deciphering the interleukin 28B variants that better predict response to pegylated interferon-alpha and ribavirin therapy in HCV/HIV-1 coinfected patients . PLoS ONE7 ( 2 ), e31016 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bibert S , RogerT , CalandraTet al. IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction . J. Exp. Med.210 ( 6 ), 1109 – 1116 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• O’brien TR , Prokunina-OlssonL , DonnellyRP . IFN-lambda4: the paradoxical new member of the interferon lambda family . J. Interferon Cytokine Res. ( 2014 ).
   Web of Science ®Google Scholar
• Stone AE , GiuglianoS , SchnellGet al. Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cells . PLoS Pathog.9 ( 4 ), e1003316 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Metz P , ReuterA , BenderS , BartenschlagerR . Interferon-stimulated genes and their role in controlling hepatitis C virus . J. Hepatol.59 ( 6 ), 1331 – 1341 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Metz P , DazertE , RuggieriAet al. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication . Hepatology56 ( 6 ), 2082 – 2093 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Sarasin-Filipowicz M , OakeleyEJ , DuongFHet al. Interferon signaling and treatment outcome in chronic hepatitis C . Proc. Natl Acad. Sci. USA105 ( 19 ), 7034 – 7039 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Wieland S , MakowskaZ , CampanaBet al. Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver . Hepatology59 ( 6 ), 2121 – 2130 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Wieland SF , ChisariFV . Stealth and cunning: hepatitis B and hepatitis C viruses . J. Virol.79 ( 15 ), 9369 – 9380 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Lanford RE , FengZ , ChavezDet al. Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA . Proc. Natl Acad. Sci. USA108 ( 27 ), 11223 – 11228 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Chen L , BorozanI , SunJet al. Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection . Gastroenterology138 ( 3 ), 1123 – 1133e1121 – 1123 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Honda M , SakaiA , YamashitaTet al. Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C . Gastroenterology139 ( 2 ), 499 – 509 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sarasin-Filipowicz M , WangX , YanMet al. Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43 . Mol. Cell. Biol.29 ( 17 ), 4841 – 4851 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Liang Y , ShilagardT , XiaoSYet al. Visualizing hepatitis C virus infections in human liver by two-photon microscopy . Gastroenterology137 ( 4 ), 1448 – 1458 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Kandathil AJ , GrawF , QuinnJet al. Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver . Gastroenterology145 ( 6 ), 1404 – 1413 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lau DT , NegashA , ChenJet al. Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection . Gastroenterology144 ( 2 ), 402 – 413e412 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Fusco DN , BrisacC , JohnSPet al. A genetic screen identifies interferon-alpha effector genes required to suppress hepatitis C virus replication . Gastroenterology144 ( 7 ), 1438 – 1449 , 1449e1431 – 1439 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zhao H , LinW , KumthipKet al. A functional genomic screen reveals novel host genes that mediate interferon-alpha’s effects against hepatitis C virus . J. Hepatol.56 ( 2 ), 326 – 333 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Malathi K , SaitoT , CrochetN , BartonDJ , GaleMJr. , SilvermanRH . RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP . RNA16 ( 11 ), 2108 – 2119 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Han JQ , BartonDJ . Activation and evasion of the antiviral 2’-5’ oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA . RNA8 ( 4 ), 512 – 525 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Taguchi T , Nagano-FujiiM , AkutsuMet al. Hepatitis C virus NS5A protein interacts with 2’,5’-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner . J. Gen. Virol.85 ( Pt 4 ), 959 – 969 ( 2004 ).
   PubMedGoogle Scholar
• Raychoudhuri A , ShrivastavaS , SteeleR , KimH , RayR , RayRB . ISG56 and IFITM1 proteins inhibit hepatitis C virus replication . J. Virol.85 ( 24 ), 12881 – 12889 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wilkins C , WoodwardJ , LauDTet al. IFITM1 is a tight junction protein that inhibits hepatitis C virus entry . Hepatology57 ( 2 ), 461 – 469 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yao L , DongH , ZhuHet al. Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line . J. Viral Hepat.18 ( 10 ), e523 – 529 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Amini-Bavil-Olyaee S , ChoiYJ , LeeJHet al. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry . Cell Host Microbe13 ( 4 ), 452 – 464 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gao L , AizakiH , HeJW , LaiMM . Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft . J. Virol.78 ( 7 ), 3480 – 3488 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Wang H , PerryJW , LauringAS , NeddermannP , De FrancescoR , TaiAW . Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking . Gastroenterology146 ( 5 ), 1373 – 1385 , e1371 – 1311 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Helbig KJ , EyreNS , YipEet al. The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A . Hepatology54 ( 5 ), 1506 – 1517 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wang S , WuX , PanTet al. Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33 . J. Gen. Virol.93 ( Pt 1 ), 83 – 92 ( 2012 ).
   PubMedGoogle Scholar
• Arnaud N , DaboS , MaillardPet al. Hepatitis C virus controls interferon production through PKR activation . PLoS ONE5 ( 5 ), e10575 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kang W , SungPS , ParkSHet al. Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions . Gastroenterology146 ( 5 ), 1351 – 1360 , e1351 – 1354 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Taylor DR , ShiST , RomanoPR , BarberGN , LaiMM . Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein . Science285 ( 5424 ), 107 – 110 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Gale MJ , Jr. , KorthMJ , TangNMet al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein . Virology230 ( 2 ), 217 – 227 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Heim MH . Innate immunity and HCV . J. Hepatol.58 ( 3 ), 564 – 574 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Taylor DR , PuigM , DarnellME , MihalikK , FeinstoneSM . New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1 . J. Virol.79 ( 10 ), 6291 – 6298 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Dafa-Berger A , KuzminaA , FasslerM , Yitzhak-AsrafH , Shemer-AvniY , TaubeR . Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin . Virology428 ( 2 ), 98 – 111 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Itsui Y , SakamotoN , KurosakiMet al. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication . J. Viral Hepat.13 ( 10 ), 690 – 700 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Pichlmair A , LassnigC , EberleCAet al. IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA . Nat. Immunol.12 ( 7 ), 624 – 630 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Liu XY , ChenW , WeiB , ShanYF , WangC . IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1 . J. Immunol.187 ( 5 ), 2559 – 2568 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kanazawa N , KurosakiM , SakamotoNet al. Regulation of hepatitis C virus replication by interferon regulatory factor 1 . J. Virol.78 ( 18 ), 9713 – 9720 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Jiang D , GuoH , XuCet al. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus . J. Virol.82 ( 4 ), 1665 – 1678 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kwon YC , KangJI , HwangSB , AhnBY . The ribonuclease L-dependent antiviral roles of human 2′,5′-oligoadenylate synthetase family members against hepatitis C virus . FEBS Lett.587 ( 2 ), 156 – 164 ( 2013 ).
   PubMed Web of Science ®Google Scholar